A third of NHS shakes and soups diet participants achieve diabetes remission

FHS
August 8, 2024
12:51 pm

Researchers assessed insulin-independent diabetes remission by total dietary replacement in England.

Tris Pharma declares Phase 3 win for ‘opioid-like’ painkiller. Can it sell?

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

January 23, 2025

How important is inflammation and body weight in the origin of depression?

A new paper in BMC Medicine examines the role of inflammation and body mass index (BMI) in the etiology of treatment-resistant depression.

September 18, 2023

Gut-Friendlier Dose of Nintedanib Finally Backed by Some Data

HONOLULU — A reduced-dose regimen of the antifibrotic medication nintedanib (Ofev) held up in real-world clinical practice, an observational study found. Approved for the treatment

October 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.